| |
Latest 10 SEC filings (by transaction date) for GNLX within the last 6 months | [?] |
![]() ![]() |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Sep 29/23 | Sep 28/23 | Szalay Aladar | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -2,289 | $24.12 |
Sep 29/23 | Sep 27/23 | Szalay Aladar | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -11,257 | $24.47 |
Sep 27/23 | Sep 26/23 | Szalay Aladar | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -9,600 | $24.51 |
Sep 27/23 | Sep 26/23 | Szalay Aladar | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -12,740 | $24.03 |
Sep 27/23 | Sep 26/23 | Szalay Aladar | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -7,465 | $22.47 |
Sep 27/23 | Sep 26/23 | Yu Yong | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 ![]() | -5,200 | |
Sep 27/23 | Sep 26/23 | Yu Yong | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -2,203 | $24.46 |
Sep 27/23 | Sep 26/23 | Yu Yong | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -1,114 | $23.51 |
Sep 27/23 | Sep 26/23 | Yu Yong | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -1,883 | $22.54 |
Sep 27/23 | Sep 26/23 | Yu Yong | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 5,200 | $6.00 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for GNLX within the last 6 months | [?] |
![]() ![]() |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Sep 29/23 | Sep 28/23 | Szalay Aladar | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -2,289 | $24.12 |
Sep 29/23 | Sep 27/23 | Szalay Aladar | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -11,257 | $24.47 |
Sep 27/23 | Sep 26/23 | Szalay Aladar | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -9,600 | $24.51 |
Sep 27/23 | Sep 26/23 | Szalay Aladar | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -12,740 | $24.03 |
Sep 27/23 | Sep 26/23 | Szalay Aladar | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -7,465 | $22.47 |
Sep 27/23 | Sep 25/23 | Szalay Aladar | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -1,100 | $27.81 |
Sep 27/23 | Sep 25/23 | Szalay Aladar | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -1,900 | $26.60 |
Sep 27/23 | Sep 25/23 | Szalay Aladar | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -5,511 | $25.75 |
Sep 27/23 | Sep 25/23 | Szalay Aladar | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -3,947 | $24.82 |
Sep 27/23 | Sep 26/23 | Yu Yong | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 ![]() | -5,200 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Lexicon Pharmaceuticals (OQ:LXRX) |
MoonLake Immunotherapeuti (OQ:MLTX) |
Ventyx Biosciences (OQ:VTYX) |